Israel Ischemic Heart Disease Market (2025-2031) | Companies, Industry, Size & Revenue, Forecast, Growth, Value, Analysis, Share, Segmentation, Outlook, Competitive Landscape, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Ischemic Heart Disease Market Revenues & Volume, 2021 & 2031F

3.3 Israel Ischemic Heart Disease Market - Industry Life Cycle

3.4 Israel Ischemic Heart Disease Market - Porter's Five Forces

3.5 Israel Ischemic Heart Disease Market Revenues & Volume Share, By Disease, 2021 & 2031F

3.6 Israel Ischemic Heart Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of risk factors such as obesity, diabetes, and hypertension leading to a higher incidence of ischemic heart disease in Israel.

4.2.2 Growing aging population in Israel contributing to a higher demand for cardiovascular healthcare services.

4.2.3 Technological advancements in diagnostic tools and treatment options improving patient outcomes and increasing market opportunities.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of new cardiovascular drugs and devices leading to longer timelines for market entry.

4.3.2 High cost associated with advanced cardiovascular treatments and procedures limiting accessibility for some patients in Israel.

6.1 Israel Ischemic Heart Disease Market, By Disease

6.1.1 Overview and Analysis

6.1.2 Israel Ischemic Heart Disease Market Revenues & Volume, By Disease, 2021- 2031F

6.1.3 Israel Ischemic Heart Disease Market Revenues & Volume, By Angina Pectoris, 2021- 2031F

6.1.4 Israel Ischemic Heart Disease Market Revenues & Volume, By Myocardial Infarction, 2021- 2031F

6.2 Israel Ischemic Heart Disease Market, By Drug Class

6.2.1 Overview and Analysis

6.2.2 Israel Ischemic Heart Disease Market Revenues & Volume, By Anti-Dyslipidemic Drugs, 2021- 2031F

6.2.3 Israel Ischemic Heart Disease Market Revenues & Volume, By Beta-Blockers, 2021- 2031F

6.2.4 Israel Ischemic Heart Disease Market Revenues & Volume, By ACE Inhibitors, 2021- 2031F

6.2.5 Israel Ischemic Heart Disease Market Revenues & Volume, By ARBs, 2021- 2031F

6.2.6 Israel Ischemic Heart Disease Market Revenues & Volume, By Vasodilators, 2021- 2031F

6.2.7 Israel Ischemic Heart Disease Market Revenues & Volume, By Antithrombotic Agents, 2021- 2031F

7.1 Israel Ischemic Heart Disease Market Export to Major Countries

7.2 Israel Ischemic Heart Disease Market Imports from Major Countries

8.1 Average waiting time for cardiovascular procedures in Israel.

8.2 Percentage of population undergoing regular cardiovascular screenings.

8.3 Adoption rate of telemedicine solutions for cardiovascular care in Israel.

9.1 Israel Ischemic Heart Disease Market Opportunity Assessment, By Disease, 2021 & 2031F

9.2 Israel Ischemic Heart Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

10.1 Israel Ischemic Heart Disease Market Revenue Share, By Companies, 2024

10.2 Israel Ischemic Heart Disease Market Competitive Benchmarking, By Operating and Technical Parameters